Articles by Kristen Mueller, Ph.D., MRA Scientific Program Director


Understanding Neoantigens: A Critical Target for Improving Immunotherapy

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 20 January 2017

The approval of eleven new therapies for melanoma since 2011 has led to dramatic changes in how doctors treat melanoma and even more importantly, has led to better outcomes for many patients. Chief among the new therapies are those that target the immune system.

Read More


About the Author
Kristen Mueller, Ph.D., MRA Scientific Program Director


Login

×